IL-4 INDUCES CHEMOTAXIS OF BLOOD EOSINOPHILS FROM ATOPIC-DERMATITIS PATIENTS, BUT NOT FROM NORMAL INDIVIDUALS

被引:48
作者
DUBOIS, GR
BRUIJNZEELKOOMEN, CAFM
BRUIJNZEEL, PLB
机构
[1] TNO,DEPT PHARMACOL,MED BIOL LAB,2288 GJ RIJSWIJK,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT DERMATOL ALLERGOL,UTRECHT,NETHERLANDS
[3] SWISS INST ALLERGY & ASTHMA RES,DAVOS,SWITZERLAND
关键词
ATOPIC DERMATITIS; CYTOKINES; EOSINOPHILS; MIGRATION; INTERLEUKIN; 4;
D O I
10.1111/1523-1747.ep12382362
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
T lymphocytes present in allergically inflamed tissue synthesize and secrete the cytokines interleukin (IL)-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor (GM-CSF). IL-3, IL-5, and GM-CSF, but also IL-4, may act as a chemotaxin on eosinophils. In contrast to the former cytokines, IL-4 is only chemotactic for eosinophils from the peripheral blood of patients with atopic dermatitis and not for eosinophils from normal individuals. IL-4 has the same chemotactic potency as the other cytokines. The optimal chemotactic potency is reached at a concentration of 10 nM. In contrast, neutrophils do not respond chemotactically to IL-4. Checkerboard analysis, inhibition studies with monoclonal anti-IL-4 antibodies, and desensitization experiments indicated specific interaction of IL-4 with eosinophils. In eosinophils from normal individuals, IL-4 responsiveness could be induced by pretreatment of the cells with IL-5 and GM-CSF. In addition to the fact that IL-4 may be responsible for selective eosinophil transendothelial migration, IL-4 may exert an important modulatory mode of action on eosinophil migration and function within allergically inflamed tissue. Our findings suggest the presence of a functional IL-4R on eosinophils from atopic dermatitis patients.
引用
收藏
页码:843 / 846
页数:4
相关论文
共 23 条
[1]   EOSINOPHIL MIGRATION IN ATOPIC DERMATITIS-I - INCREASED MIGRATORY RESPONSES TO N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE, NEUTROPHIL-ACTIVATING FACTOR, PLATELET-ACTIVATING-FACTOR, AND PLATELET FACTOR-IV [J].
BRUIJNZEEL, PLB ;
KUIJPER, PHM ;
RIHS, S ;
BETZ, S ;
WARRINGA, RAJ ;
KOENDERMAN, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (02) :137-142
[2]  
BRUIJNZEELKOOME.C, 1988, BRIT J DERMATOL, V118, P229
[3]  
BRUIJNZEELKOOMEN C, 1990, ALLERGOLOGIE, V13, P325
[4]   HUMAN RECOMBINANT INTERLEUKIN-4 INDUCES FC-EPSILON RECEPTORS (CD23) ON NORMAL HUMAN LYMPHOCYTES-B [J].
DEFRANCE, T ;
AUBRY, JP ;
ROUSSET, F ;
VANBERVLIET, B ;
BONNEFOY, JY ;
ARAI, N ;
TAKEBE, Y ;
YOKOTA, T ;
LEE, F ;
ARAI, K ;
DEVRIES, J ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1459-1467
[5]  
HANIFIN JM, 1980, ACTA DERM-VENEREOL, V92, P44, DOI [DOI 10.2340/00015555924447, 10.2340/00015555924447]
[6]   IDENTIFICATION OF A T-CELL-DERIVED B-CELL GROWTH-FACTOR DISTINCT FROM INTERLEUKIN-2 [J].
HOWARD, M ;
FARRAR, J ;
HILFIKER, M ;
JOHNSON, B ;
TAKATSU, K ;
HAMAOKA, T ;
PAUL, WE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (03) :914-923
[7]   MURINE B-CELL STIMULATORY FACTOR-I (INTERLEUKIN-4) INCREASES EXPRESSION OF THE FC RECEPTOR FOR IGE ON MOUSE B-CELLS [J].
HUDAK, SA ;
GOLLNICK, SO ;
CONRAD, DH ;
KEHRY, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (13) :4606-4610
[8]  
LAWAHAMI Y, 1988, J EXP MED, V168, P85
[9]  
LEIFERMAN K, 1985, NEW ENGL J MED, V313, P47
[10]  
MOSER R, 1992, J IMMUNOL, V149, P1432